Valuation check: ICCM's profit margin is -427.67%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ICCM is -427.67% as of June 2026. That compares with -559.02% in the prior-year period — up 23.5% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Icecure Medical's historical trend and sector peers before judging valuation or financial health.
Over the past year, ICCM's profit margin moved from -559.02% to -427.67% — a 23.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Icecure Medical's valuation or profitability profile.
Against Healthcare companies, ICCM currently prints -427.67% for profit margin, while the sector average sits near 21.34%. That is roughly 2104.5% below the sector mean. Large gaps often invite a closer look at Icecure Medical's growth, margins, and balance sheet.
Profit Margin shows how effectively Icecure Medical converts resources into returns. At -427.67%, ICCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -559.02% in the prior-year period — up 23.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ICCM's profit margin (-427.67%), review year-over-year change from -559.02%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.